The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2016

Filed:

Jan. 17, 2013
Applicant:

Sanofi Pasteur, Lyons, FR;

Inventors:

Landry Bertaux, Lyons, FR;

Isabelle Chacornac, Tupin et Semons, FR;

Alain Françon, Bessenay, FR;

Jean-François Hau, Rouen, FR;

Sandrine Lentsch Graf, Sainte Foy les Lyon, FR;

Assignee:

SANOFI PASTEUR, Iyon, FR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/385 (2006.01); A61K 47/02 (2006.01); A61K 39/12 (2006.01); A61K 39/102 (2006.01); A61K 39/29 (2006.01); C12N 7/00 (2006.01); A61K 39/05 (2006.01); A61K 39/08 (2006.01); A61K 39/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/02 (2013.01); A61K 39/05 (2013.01); A61K 39/08 (2013.01); A61K 39/099 (2013.01); A61K 39/102 (2013.01); A61K 39/12 (2013.01); A61K 39/29 (2013.01); C12N 7/00 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/70 (2013.01); C12N 2710/00034 (2013.01); C12N 2730/10134 (2013.01); C12N 2770/32634 (2013.01);
Abstract

The subject matter of the invention is a method for preparing a vaccine composition comprising at least aluminum oxyhydroxide (AlOOH), and at least the hepatitis B surface antigen and thetype b antigen. According to the invention, the hepatitis B surface antigen is kept adsorbed on the AlOOH, whereas the Hib antigen is kept nonadsorbed. To this end: the hepatitis B surface antigen is adsorbed onto AlOOH in order to obtain an AlOOH/HBsAg complex, then—said AlOOH/HBsAg complex is mixed with the Hib antigen in the presence of cationic amino acids at a concentration of at least 100 mg/l, and of phosphate ions at a concentration of 35 to 45 mMol/l.


Find Patent Forward Citations

Loading…